The settlement centers on the Delaware-based company’s efforts to promote Seroquel, which the Food and Drug Administration has approved to treat disorders such as schizophrenia and bipolar depression. The government alleges that AstraZeneca aggressively marketed the drug for unapproved uses — such as to treat Alzheimer’s disease and anxiety — to physicians, who then put [...]
Continue reading...Sunday, July 27, 2008
Zyprexa was FDA approved for the short-term treatment of acute manic episodes in bipolar disorder. The worlds best selling schizophrenia drug, Zyprexa sales account for 40% of Eli Lillys $11.08 billion in sales. There have been many questions regarding the popular drug Zyprexa and its safety. Linked to 288 reported Zyprexa diabetes cases, including 23 [...]
Continue reading...
Tuesday, April 27, 2010
0 Comments